These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 26473632)

  • 1. Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A French Nationwide Study of Ninety-Two Patients.
    Crickx E; Machelart I; Lazaro E; Kahn JE; Cohen-Aubart F; Martin T; Mania A; Hatron PY; Hayem G; Blanchard-Delaunay C; de Moreuil C; Le Guenno G; Vandergheynst F; Maurier F; Crestani B; Dhote R; Silva NM; Ollivier Y; Mehdaoui A; Godeau B; Mariette X; Cadranel J; Cohen P; Puéchal X; Le Jeunne C; Mouthon L; Guillevin L; Terrier B;
    Arthritis Rheumatol; 2016 Mar; 68(3):702-12. PubMed ID: 26473632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin therapy in antineutrophil cytoplasmic antibody-associated vasculitis.
    Benavides-Villanueva F; Loricera J; Calvo-Río V; Corrales-Selaya C; Castañeda S; Blanco R
    Eur J Intern Med; 2023 Nov; 117():78-84. PubMed ID: 37400322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
    Lally L; Spiera R
    Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
    PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.
    Martinez V; Cohen P; Pagnoux C; Vinzio S; Mahr A; Mouthon L; Sailler L; Delaunay C; Sadoun A; Guillevin L;
    Arthritis Rheum; 2008 Jan; 58(1):308-17. PubMed ID: 18163506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood.
    Vanoni F; Bettinelli A; Keller F; Bianchetti MG; Simonetti GD
    Pediatr Nephrol; 2010 Feb; 25(2):205-12. PubMed ID: 19641940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulomatous Vasculitis.
    Sharma A; Dogra S; Sharma K
    Dermatol Clin; 2015 Jul; 33(3):475-87. PubMed ID: 26143427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Morishita KA; Moorthy LN; Lubieniecka JM; Twilt M; Yeung RSM; Toth MB; Shenoi S; Ristic G; Nielsen SM; Luqmani RA; Li SC; Lee T; Lawson EF; Kostik MM; Klein-Gitelman M; Huber AM; Hersh AO; Foell D; Elder ME; Eberhard BA; Dancey P; Charuvanij S; Benseler SM; Cabral DA;
    Arthritis Rheumatol; 2017 Jul; 69(7):1470-1479. PubMed ID: 28371513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: update.
    Santana AN; Woronik V; Halpern AS; Barbas CS
    J Bras Pneumol; 2011; 37(6):809-16. PubMed ID: 22241040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of ANCA-associated vasculitides (AAV).
    Holle JU; Gross WL
    Autoimmun Rev; 2013 Feb; 12(4):483-6. PubMed ID: 22921792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with seven Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis treated with remission-induction therapy with intravenous cyclophosphamide according to the CYCLOPS protocol.
    Oiwa H; Yamasaki S; Endo K; Nojima T; Kumagai K; Sugiyama E
    Intern Med; 2014; 53(20):2291-6. PubMed ID: 25318790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel diseases in anti-neutrophil cytoplasmic antibody-associated vasculitides: 11 retrospective cases from the French Vasculitis Study Group.
    Humbert S; Guilpain P; Puéchal X; Terrier B; Rivière S; Mahr A; Pagnoux C; Bagnères D; Cordier JF; Le Quellec A; Altwegg R; Guillevin L;
    Rheumatology (Oxford); 2015 Nov; 54(11):1970-5. PubMed ID: 26106214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H; Lee SM; Manno RL; Seo P; Geetha D
    Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted immunotherapy strategies in ANCA-associated vasculitis.
    Puéchal X
    Joint Bone Spine; 2019 May; 86(3):321-326. PubMed ID: 30201478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
    Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
    J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
    Mohammad AJ; Hot A; Arndt F; Moosig F; Guerry MJ; Amudala N; Smith R; Sivasothy P; Guillevin L; Merkel PA; Jayne DR
    Ann Rheum Dis; 2016 Feb; 75(2):396-401. PubMed ID: 25467294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin.
    Levy Y; Sherer Y; George J; Langevitz P; Ahmed A; Bar-Dayan Y; Fabbrizzi F; Terryberry J; Peter J; Shoenfeld Y
    Int Arch Allergy Immunol; 1999 Jul; 119(3):231-8. PubMed ID: 10436395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of ANCA-positive systemic vasculitis with intravenous immunoglobins].
    Mouthon L
    Rev Med Interne; 1999; 20 Suppl 4():431s-435s. PubMed ID: 10522318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.